Silver Book Fact

The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.

Alzheimer's Association. 2012 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2012; 8(2): 131-68. http://www.alzheimersanddementia.com/article/S1552-5260(12)00032-5/fulltext

Reference

Title
2012 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2012
Authors
Alzheimer's Association
Volume & Issue
Volume 8, Issue 2
Pages
131-68
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Americans Age 65 and Older with Alzheimer’s Disease, 2010–2050  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • In a study of different treatments for Parkinson’s disease, results showed that the disease can be managed for up to 5 years with a reduces risk of dyskinesia.  
  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • Average Annual Direct Medical Costs Per Person with Parkinson’s Disease